Benitec Biopharma (BNTC) Invested Capital (2019 - 2025)
Historic Invested Capital for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $317.7 million.
- Benitec Biopharma's Invested Capital rose 266221.74% to $317.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $317.7 million, marking a year-over-year increase of 266221.74%. This contributed to the annual value of $47.2 million for FY2024, which is 2329009.9% up from last year.
- Benitec Biopharma's Invested Capital amounted to $317.7 million in Q1 2025, which was up 266221.74% from $281.5 million recorded in Q4 2024.
- Over the past 5 years, Benitec Biopharma's Invested Capital peaked at $317.7 million during Q1 2025, and registered a low of $202000.0 during Q2 2023.
- In the last 5 years, Benitec Biopharma's Invested Capital had a median value of $14.6 million in 2022 and averaged $50.4 million.
- As far as peak fluctuations go, Benitec Biopharma's Invested Capital plummeted by 9299.1% in 2023, and later soared by 2329009.9% in 2024.
- Quarter analysis of 5 years shows Benitec Biopharma's Invested Capital stood at $10.8 million in 2021, then decreased by 17.0% to $9.0 million in 2022, then skyrocketed by 72.0% to $15.5 million in 2023, then surged by 1719.64% to $281.5 million in 2024, then rose by 12.84% to $317.7 million in 2025.
- Its Invested Capital was $317.7 million in Q1 2025, compared to $281.5 million in Q4 2024 and $64.2 million in Q3 2024.